Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

I'rom Group Co., Ltd. (2372.T)

Tokyo - Tokyo Delayed Price. Currency in JPY
Add to watchlist
1,541.00-6.00 (-0.39%)
At close: 03:15PM JST
Advertisement

I'rom Group Co., Ltd.

Iidabashi Grand Bloom
2-10-2, Fujimi Chiyoda-ku
Tokyo 102-0071
Japan
81 3 3264 3148
https://www.iromgroup.co.jp

Sector(s)Healthcare
IndustryMedical Care Facilities
Full Time Employees810

Key Executives

NameTitlePayExercisedYear Born
Mr. Toyotaka MoriChief Exec. Officer, Pres and DirectorN/AN/A1958
Mr. Masaaki MatsushimaSr. Managing DirectorN/AN/A1964
Mr. Kiyoshi WatanabeExec. VPN/AN/A1958
Hiroaki InukaiExec. VPN/AN/A1966
Mr. Toshiya HaraExec. VPN/AN/A1970
Amounts are as of and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in JPY.

Description

I'rom Group Co., Ltd. engages in the advanced medicinal treatment, site management organization, contract research organization, and medical support businesses in Japan. The company engages in the development of medical technologies, such as regenerative medicine and gene therapy for obstructive arteriosclerosis, retinitis pigmentosa, and human immunodeficiency virus infection and acquired immune deficiency syndrome, as well as Sendai virus vector and CytoTune-iPS, a kit for generating iPS cells. It also supports medical institutions in conducting clinical trials; provides clinical trial support services for new drug development and medical equipment for cancer, and rare and intractable diseases; and establishes and operates clinic malls. The company was formerly known as I'Rom Holdings Co., Ltd. and changed its name to I'rom Group Co., Ltd. in July 2015. I'rom Group Co., Ltd. was founded in 1997 and is headquartered in Tokyo, Japan.

Corporate Governance

I'rom Group Co., Ltd.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Advertisement
Advertisement